Emerging Therapies for Eosinophilic Gastrointestinal Diseases

Abstract

Besides eosinophilic esophagitis, other eosinophilic gastrointestinal diseases (EGIDs), such as eosinophilic gastritis, eosinophilic gastroenteritis, and eosinophilic colitis, are increasingly diagnosed over the last decade. Whereas diagnosis and therapy of eosinophilic esophagitis have been standardized, the diagnosis and therapy of other EGIDs are areas of active research. Motivated by the increasing prevalence of these conditions, concerted efforts of different stakeholders have led to the evaluation of targeted biologic therapies for EGID management over the last couple of years, and several promising molecules are currently in the pipeline. This review article provides an overview of targeted biologic therapies for use in EGIDs.

Keywords: Eosinophil gastrointestinal disorder; Eosinophilic colitis; Eosinophilic esophagitis; Eosinophilic gastroenteritis; IL-4 receptor antibody; IL-5 antibody; Siglec-8 antibody.